thirty-seven nonazotemic cirrhotic patients with ascites were randomly allocated to receive for 2 weeks bumetanide ( group a , n = 13 ) , spironolactone ( group b , n = 12 ) or a combination of the two drugs ( group c , n = 12 ) after a 5-day stabilization period .
C0003962
ascites
C0037982
spironolactone